NO961046L - Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre - Google Patents
Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyreInfo
- Publication number
- NO961046L NO961046L NO961046A NO961046A NO961046L NO 961046 L NO961046 L NO 961046L NO 961046 A NO961046 A NO 961046A NO 961046 A NO961046 A NO 961046A NO 961046 L NO961046 L NO 961046L
- Authority
- NO
- Norway
- Prior art keywords
- hirudin
- patients
- acetylsalicylic acid
- undergo
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Det er oppdaget at administrering av kombinasjonen av hirudin og acetylsalicylsyre (ASA) til pasienter som ikke gjennomgår behandling med et trombolytisk middel, inhiberer og/eller forhindrer myokardial eller kardiovaskulære tilstander i pasienten. Det er beskrevet en farmasøytisk kombinasjon av et blodplate inaktiverende medikament, acetylsalicylsyre og en direkte trombininhibitor, hirudin, for behandling av pasienter med akutt myokardial infarkt som ikke gjennomgår trombolyse. En farmasøytisk sammensetning som omfatter den synergistiske kombinasjonen av hirudin og ASA, i fravær av et trombolytisk middel, er spesielt nyttig i terapeutiske og profylaktiske i metoder som er beskrevet.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40526995A | 1995-03-15 | 1995-03-15 | |
| US44055695A | 1995-05-12 | 1995-05-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO961046D0 NO961046D0 (no) | 1996-03-14 |
| NO961046L true NO961046L (no) | 1996-09-16 |
Family
ID=27019016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961046A NO961046L (no) | 1995-03-15 | 1996-03-14 | Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0732102A3 (no) |
| JP (1) | JPH0920681A (no) |
| KR (1) | KR960033468A (no) |
| CN (1) | CN1141809A (no) |
| AR (1) | AR002968A1 (no) |
| AU (1) | AU711660B2 (no) |
| BR (1) | BR9601024A (no) |
| CA (1) | CA2171509A1 (no) |
| FI (1) | FI961171A7 (no) |
| IL (1) | IL117485A0 (no) |
| NO (1) | NO961046L (no) |
| NZ (1) | NZ286082A (no) |
| SG (1) | SG43242A1 (no) |
| UY (1) | UY24181A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004262776A (ja) * | 2003-02-21 | 2004-09-24 | Teikoku Seiyaku Co Ltd | 血管新生促進剤 |
| JP4855073B2 (ja) * | 2003-09-19 | 2012-01-18 | キッセイ薬品工業株式会社 | 併用医薬 |
| US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
| JP2009543842A (ja) * | 2006-07-17 | 2009-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 心臓血管分野における直接トロンビン阻害薬のための新規適応 |
-
1996
- 1996-02-27 NZ NZ286082A patent/NZ286082A/en unknown
- 1996-02-29 SG SG1996006166A patent/SG43242A1/en unknown
- 1996-03-11 CA CA002171509A patent/CA2171509A1/en not_active Abandoned
- 1996-03-12 AR ARP960101719A patent/AR002968A1/es unknown
- 1996-03-12 EP EP96103821A patent/EP0732102A3/en not_active Withdrawn
- 1996-03-13 AU AU48072/96A patent/AU711660B2/en not_active Ceased
- 1996-03-13 FI FI961171A patent/FI961171A7/fi unknown
- 1996-03-14 CN CN96101995A patent/CN1141809A/zh active Pending
- 1996-03-14 NO NO961046A patent/NO961046L/no not_active Application Discontinuation
- 1996-03-14 IL IL11748596A patent/IL117485A0/xx unknown
- 1996-03-14 JP JP8057083A patent/JPH0920681A/ja active Pending
- 1996-03-14 KR KR1019960006762A patent/KR960033468A/ko not_active Withdrawn
- 1996-03-15 UY UY24181A patent/UY24181A1/es unknown
- 1996-03-15 BR BR9601024A patent/BR9601024A/pt active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| AU711660B2 (en) | 1999-10-21 |
| UY24181A1 (es) | 1996-03-20 |
| FI961171L (fi) | 1996-09-16 |
| AR002968A1 (es) | 1998-05-27 |
| CN1141809A (zh) | 1997-02-05 |
| SG43242A1 (en) | 1997-10-17 |
| FI961171A0 (fi) | 1996-03-13 |
| JPH0920681A (ja) | 1997-01-21 |
| EP0732102A3 (en) | 1999-01-27 |
| IL117485A0 (en) | 1996-07-23 |
| NO961046D0 (no) | 1996-03-14 |
| AU4807296A (en) | 1996-09-26 |
| FI961171A7 (fi) | 1996-09-16 |
| KR960033468A (ko) | 1996-10-22 |
| NZ286082A (en) | 1998-09-24 |
| CA2171509A1 (en) | 1996-09-16 |
| BR9601024A (pt) | 1997-12-30 |
| EP0732102A2 (en) | 1996-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI922325A0 (fi) | Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar. | |
| ID24901A (id) | Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh | |
| AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
| NO972475L (no) | Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav | |
| UA41398C2 (uk) | Спосіб лікування пацієнта і спосіб зниження ризику кровотеч та крововиливів в мозок у хворого, який потребує тромболітичної терапії, фармацевтична комбінація у формі заздалегідь упакованої одиниці і фармацевтична пакувальна одиниця, що складається з цієї комбінації | |
| MX9709977A (es) | Compuestos de (acido sulfinico, acido sulfonico, sulfonilamino o sulfinilamino) n-[(aminoiminometil) fenilalquil] azaheterociclilamida sustituidos. | |
| EP0671414A4 (en) | ANTITHROMBOTIC. | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| MD1521F2 (en) | Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states | |
| NO934832L (no) | Farmasöytisk sammensetning for forhindring eller behandling av arterioscherose | |
| AR002968A1 (es) | Uso de hirudina y acido acetilsalicilico para la preparacion de un medicamento para tratar un infarto de miocardio agudo en pacientes nosometidos a tratamiento trombolitico y una composicion farmaceutica. | |
| Shulman | Heparin and atherosclerosis: an investigative report on the treatment of atherosclerosis | |
| NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
| ATE257377T1 (de) | Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform | |
| Harjola et al. | The effect of dipyridamole and warfarin on the patency rate of coronary artery bypass grafts | |
| Brenman | Pentoxifylline as adjunctive therapy in leg ulcer management | |
| Taylor et al. | Treatment options for rapid-cycling bipolar affective disorder | |
| Boldt | RETRACTED: Invited letter concerning: Aprotinin use in pediatric cardiac operations: Reply to the Editor | |
| Marder | Thrombolytic agents: Balancing cost, efficacy, and side effects | |
| EA199700025A1 (ru) | Применение олигосахарида и аспирина для приготовления медикаментов, предназначенных для лечения тромбоэмболических заболеваний, фармацевтическая композиция, способ лечения | |
| Ellis Jr | Tissue expansion as an adjunct to reconstruction of congenital and acquired auricular deformities: Chana JS, Grobbelaar AO, Gault DT. Br J Plast Surg 50: 456, 1997 | |
| UA9672A (uk) | Спосіб лікування деструктивних форм гострого панкреатиту | |
| RU94020918A (ru) | Способ лечения опсоменореи |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |